InSysBio announces the upcoming workshop on Heta at Quantitative Systems Pharmacology Conference (QSPC 2026). The worksop will be held at Golden Tulip & Tulip Inn Leiden Centre, Leiden, the Netherlands on April 7, 2026, 1 PM – 5 PM.
This workshop introduces an engineering-oriented approach to quantitative systems pharmacology (QSP) modeling using the Heta language and its associated tools. The session focuses on how structured, modular, and process-based model descriptions can improve transparency, reuse, and reproducibility compared to traditional monolithic ODE-based workflows. Participants will be introduced to the core concepts of the Heta language, including process-based model formulation, modularization, and alternative model representations, with an emphasis on how these ideas support scalable QSP workflows rather than on detailed syntax or implementation.
The workshop demonstrates how Heta models are used in practice: from model specification to translation into standard formats and execution with different simulation tools. The session includes guided demonstrations of model conversion using the Heta compiler, basic simulation workflows with HetaSimulator, and an overview of a typical Heta project structure. Short, optional hands-on segments are included for participants who wish to follow along, while others may simply observe the demonstrations. The workshop is intended as an accessible entry point for researchers interested in engineering-style QSP workflows and evaluating whether such an approach fits their existing modeling practice.
What You Will Learn
Who Should Attend
The workshop is free of charge.
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio's cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | September 2024 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
|
3
|
4
1.
04 Sep 2024 16:07
Now B cells model reflects the current views on the processes
InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system
|
5
|
6
|
7
|
8
|
|
9
|
10
1.
10 Sep 2024 18:36
InSysBio team to publish the new article in PSPJournal
The new article "Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms" by Olga Ivanova and Tatiana Karelina was published in PSPJournal at the end of August 2024
|
11
1.
11 Sep 2024 15:25
InSysBio to take part in ACoP 2024
InSysBio announces its participation in the 15th American Conference on Pharmacometrics (ACoP). Oleg Demin Jr, Scientific Director, Oncology & Immuno-Oncology, will be a co-chair and speaker of the session "Advancing QSP: From Virtual Patient To Digital Twin". InSysBio team is going to present its modeling services & software to optimize drug development at the Booth #11 and 9 posters in frames of the Conference
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
|
30
| ||||||